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S U M M A R Y
Background and aim: Infective endocarditis (IE) is associated with increased mortality and morbidity. In
this study, we aimed to evaluate the role of troponin levels in predicting long-term survival in patients
with IE.
Methods: A retrospective analysis of the medical database of Yuksek Ihtisas Education and Research
Hospital was performed to reach the patients that received the diagnosis of deﬁnite IE according to Duke
criteria. Out of 84 deﬁnite IE cases, 48 patients (mean age 45.617.3, 39.6% female) that had troponin T
levels measured upon hospital admission were included. The survival status of the study subjects was
assessed during a follow-up period of 1 year.
Results: A total of 20 (41.7%) patients died during the follow-up. Baseline median troponin T levels were
signiﬁcantly higher in fatal cases (0.08 [0.02-0.24] ng/ml vs. 0.02 [0.01-0.04] ng/ml p=0.003). The optimal
troponin T level to detect mortality was 0.05 ng/ml according to receiver operating characteristic curve
(area under the curve 0.75, 95% Conﬁdence Interval (CI) [0.61-0.9], p=0.003) with 70% sensitivity and 79%
speciﬁcity. Patient with elevated troponin levels were older, were more likely to be male and tended to
have enterococcal infection. These patients had also higher creatinine levels and increased systolic
pulmonary pressures. In the multivariate Cox regression analysis, renal failure (hazards ratio (HR) 8.23,
CI 95% 2.53-26.9, p<0.0001), heart failure (HR 4.48, CI 95% 1.73-11.61, p=0.002) and troponin T 
0.05 ng/ml (HR 3.11, CI 95% 1.13-8.56, p=0.03) were associated with increased mortality rates.
Conclusions: IE has poor outcome and baseline troponin T levels may predict long-term survival rates in
these patients.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Infective endocarditis (IE) is associated with considerable
mortality and morbidity rates despite recent improvements in
the management of the cardiovascular diseases. In-hospital
mortality rates range from 10% to 20%, while long-term mortality
rates can be much higher [1–3].
IE has a broad range of course and identifying individuals who
are at increased risk of adverse outcomes is challenging due to
interaction of various factors. The immune status of the host,
foreign body involvements, underlying heart disease, causative* Corresponding author. Address: Gu¨lbeng Sitesi G Blok No:21 Yas¸ amkent
ANKARA / TURKEY, 06820. Tel.: +90 505 8956416; fax: +90 312 6213503.
E-mail address: esragucuk@hotmail.com (E. Gucuk Ipek).
http://dx.doi.org/10.1016/j.ijid.2015.03.004
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).microorganism, and the region of the infection may all alter the
course of this complex disease. Various clinical predictors have
been proposed to estimate the outcome, but these parameters
generally emerge overtime [1,4]. Indications and timing of the
surgery, or duration of the antimicrobial therapy are still a matter
of debate; therefore a powerful biomarker may facilitate risk
stratiﬁcation to make decision on these critical points, especially at
the early stages of the disease.
Troponins are cardiac speciﬁc proteins that are released in case
of myocardial injury. Besides well-known relationship with
troponins and adverse outcome in acute coronary syndrome,
similar associations have also been demonstrated in other cardiac
and non-cardiac settings [5]. Recent studies have demonstrated
that high troponin levels can be detected in IE and elevated
troponin levels are associated with adverse outcome in patients
with IE [6,7]. However, to date no study has evaluated the role ofciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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study, we aimed to investigate the relationship between troponin
levels and 1-year survival status in patients with IE.
2. Methods
2.1. Study Patients
The medical database of Yuksek Ihtisas Education and
Research Hospital, Ankara, Turkey was reviewed retrospectively.
Between January 2008 and January 2011, 84 consecutive
patients diagnosed with deﬁnite IE according to the modiﬁed
Duke criteria were enrolled [8]. Of all cases, 48 patients that had
troponin T levels measured upon hospital admission (within
48 hours of initial admission) were included. Clinical, echocar-
diographic, and laboratory ﬁndings were recorded for each
subject. Predisposing heart diseases including prosthetic valve,
pre-existing valvular disease (rheumatic heart disease and
degenerative valves), congenital heart disease, implantable
cardiac device, nosocomial infection and previous history of
IE were assessed. Hypertension was deﬁned as blood pressure
>140/90 mm Hg on >2 occasions during ofﬁce measurements or
use of antihypertensive treatment. Coronary artery disease was
considered to be present when there was documented coronary
stenosis of >50%.
Complications during hospitalization such as heart failure,
renal failure, abscess formation, cerebrovascular events and
surgical treatment for IE were recorded. Cerebrovascular events
referred to the one of the following presentations: intracranial
hemorrhage, ischemic stroke, and transient ischemic attacks. Renal
failure was deﬁned by serum creatinine concentration exceeding
2 mg/dl during hospital stay. The primary end point of the study
was the incidence of all cause death within one year after the index
hospitalization. Clinical event data were collected during the
follow-up period for all patients by reviewing medical ﬁles and by
telephone contacts. One-year follow-up was completed in all of the
patients. The study was performed in accordance with the
Declaration of Helsinki for human research and was approved
by the local ethics committee.
2.2. Laboratory
Blood samples for troponin T were obtained upon admission
and measured with an auto analyzer (Elecsys 2010) running
commercial assays (Roche Diagnostics, Penzberg, Germany). This
assay was reported in ng/ml and the upper reference limit (99th
percentile) was < 0.01ng/ml in studies performed with healthy
volunteers. Hemoglobin and white blood cell counts were
measured using an automated hematology analyzer. C reactive
protein (CRP), glucose and creatinine levels were measured
accordingly. At least 3 sets of blood samples for cultures were
obtained from each patient immediately after hospital admis-
sion. Any other available ﬂuid, tissue (valves, vegetations or
intracardiac abscesses removed at surgery) or foreign body
samples (pacemaker leads, catheters) were used to isolate
microorganisms.
2.3. Echocardiography
All patients underwent two-dimensional transthoracic echo-
cardiography within 24 hours of admission. Echocardiographic
examinations were performed with the Vivid 7 system (GE
Healthcare, Wauwatosa, Wisconsin). Transesophageal echocardi-
ography was performed when image quality with transthoracic
echocardiography was not sufﬁcient for an accurate diagnosis; or
in cases of high clinical suspicion of IE, prosthetic valveinvolvement, and suspicion of complications. Vegetation, abscess
formation, and valvular destruction (such as perforation of leaﬂet
and chordal rupture) were noted. Vegetation size was measured by
using different echocardiographic windows, and the maximal
length was obtained. Existence of rocking motion of the prosthetic
valve with an excursion of > 158 in at least one direction led to the
diagnosis of dehiscence. Left ventricular ejection fraction was
calculated by the modiﬁed Simpson method. Severe valvular
regurgitation was identiﬁed according to guideline recommenda-
tions [9]. Continuous-wave Doppler of the tricuspid regurgitation
jet signal using the Bernoulli equation estimated pulmonary artery
systolic pressure [10].
2.4. Statistics
Continuous variables were expressed as mean  SD or as
median with interquartile range; and categorical variables were
expressed as number and percentages. Categorical variables were
compared with x2 test or Fisher test; continuous variables were
compared with Student’s t-test or Mann-Whitney U test, as
appropriate. Spearman correlation analysis was performed to
evaluate the relation of troponin T with other variables. Receiver
operating characteristic (ROC) curve was used to detect the optimal
cut-off point of troponin T levels to estimate 1-year survival. Patients
with IE were categorized into two groups on the basis of this cut-off
value. Kaplan-Meier survival curves and log-rank values were used to
assess survival in subgroups. Univariate Cox regression analysis was
performed to assess the association of the variables with 1-year
mortality. Variables that had p<0.1 in the univariate analysis were
further analyzed with multivariate Cox regression model with
conditional stepwise method. Results of the Cox regression analysis
were reported with hazards ratios (HR) and 95% conﬁdence intervals
(CI). Statistical analysis was performed using SPSS software version
20.0 (SPSS Inc., Chicago, IL). A p value of 0.05 was considered
statistically signiﬁcant.
3. Results
Out of 84 deﬁnite IE cases, 48 patients had troponin T levels
available. Supplement 1 shows baseline characteristics of the study
subjects, and comparison of patients regarding the presence of
troponin measurement. There were differences in various param-
eters of patients with and without troponin T levels, including
presence of coronary artery disease, severe valvular regurgitation
or enteroccocal infection, but these differences were not statisti-
cally signiﬁcant.
Staphylococci species were the most common microorganisms.
Presence of a prosthetic valve was the most common predisposing
factor in the study cohort. Median duration of hospital stay was
31 days. A total of 20 (41.7%) patients died during the follow-up.
Supplement 2 shows the differences between survivors and non-
survivors. Renal failure, heart failure, and severe valvular
regurgitation were signiﬁcantly higher among non-survivors,
whereas having a surgery due to IE was associated with lower
mortality.
Baseline median troponin T levels were signiﬁcantly high in
fatal cases (0.08 [0.02-0.24] ng/ml vs. 0.02 [0.01-0.04] ng/ml,
p=0.003). There was a modest correlation between troponin levels
and age (r=0.38, p=0.008), CRP (r=0.32, p=0.03), creatinine (r=0.33,
p=0.02), and systolic pulmonary artery pressure (r=0.49, p<0.001).
The optimal troponin T level to detect mortality was 0.05 ng/ml
according to ROC curve (area under the curve 0.75, 95% CI [0.61-
0.9], p=0.003) with 70% sensitivity and 79% speciﬁty (Figure 1). Of
all patients, 19 (40%) had troponin T  0.05 mg/dl. To evaluate the
association between troponin T and clinical outcome, patients
were divided into 2 groups based on this cut-off value. Table 1
Figure 1. ROC curve for troponin levels to detect 1-year mortality. The optimal cut-
off level was 0.05 ng/ml.
Table 1
Comparison of clinical characteristics of the study patients with low vs. high troponin
All Patients (n=48) Troponin
Demographics, comorbidities and predisposing conditions
Female gender 39.6% (19) 21.1% (4
Age (years) 45.617.3 53.416
Coronary artery disease 10% (5) 15.8% (3
Hypertension 16.7% (8) 15.8% (3
Prosthetic valve 45.8% (22) 31.6% (6
Pre-existing valvular disease 39.6% (19) 57.9% (1
Congenital cardiac disease 12.5% (6) 5.3% (1
Cardiac device 8.3% (4) 15.8% (3
Nosocomial infection 16.7% (8) 31.6% (6
Previous infective endocarditis 6.3% (3) 5.3% (1
Affected valve
Aortic 47.9% (23) 52.6% (1
Mitral 35.4 (17) 26.3% (5
Tricuspid 8.3% (4) 15.8% (3
Echocardiography
Cardiac abscess 10.4% (5) 21.1% (4
Severe valvular regurgitation 27.1% (13) 36.8% (7
Vegetation 10 mm 50% (24) 57.9% (1
Valvular destruction/dehiscence 14.6% (7) 15.8% (3
Pulmonary artery pressure (mm Hg) 45 (36.3-50) 48 (40-
Left ventricular ejection fraction (%) 58 (50-60) 59 (45-
Laboratory parameters on admission
Hemoglobin (g/dl) 10.82.2 10.32.
C reactive protein (mg/dl) 16 (4.2-63.6) 30.4 (12
Creatinine (mg/dl) 0.9 (0.66-1.39) 1.09 (0
Glucose (mg/dl) 100 (88-126.8) 106 (87-
White blood cell count (x10^3/uL) 10.4 (7.9-14.5) 10.5 (9.
In-hospital outcome
Renal failure 47.9% (23) 57.9% (1
Cerebrovascular events 16.7% (8) 26.3% (5
Heart failure 25% (12) 36.8% (7
Surgery 27.1% (13) 26.3% (5
Outcome at 1 year follow-up
Mortality 20 (41.7%) 13 (68.4
Microorganism
Staphylococcus Aureus 20.8% (10) 21.1% (4
Coagulase-negative Staphylococcus 14.6% (7) 26.3% (5
Streptococci 14.6% (7) 10.5% (2
Brucella spp 4.2% (2) 0% (0) 
Enterococci 12.5% (6) 26.3% (5
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0.05 ng/ml vs. < 0.05 ng/ml) regarding their demographic, clinical
and echocardiographic properties. Patients with elevated troponin
levels were older, more likely to be male, tend to have Enterococci
infection, and had higher creatinine levels as well as increased
systolic pulmonary artery pressures. There were no signiﬁcant
differences in cardiac abscess, heart failure, cerebrovascular event
or renal failure between groups.
In Kaplan Meier survival analysis, 1-year mortality rates were
signiﬁcantly higher in patients with elevated troponin T levels
(p=0.002) (Figure 2). Results of the univariate and multivariate Cox
regression analysis are listed in Table 2. In the multivariate Cox
regression analysis, renal failure (HR 8.23, CI 95% 2.53-26.9,
p<0.0001), heart failure (HR 4.48, CI 95% 1.73-11.61, P=0.002) and
troponin T  0.05 ng/ml (HR 3.11, CI 95% 1.13-8.56, p=0.03) were
associated with increased mortality rates.
4. Discussion
In our study cohort, 20 (41.7%) patients died during the follow-
up period of 1 year. There was an independent association between
troponin T levels and poor outcome, suggesting that baseline
troponin T may become a valuable biomarker to estimate poor
outcome in patients with IE. To the best of our knowledge, this is
the ﬁrst study that evaluated the association of troponin levels
with long-term mortality in IE. levels
  0.05 ng/ml (n=19) Troponin < 0.05 ng/ml (n=29) p value
) 51.7% (15) 0.03
.9 40.515.8 0.01
) 6.9% (2) 0.37
) 17.2% (5) 1
) 55.2% (16) 0.11
1) 27.6% (8) 0.04
) 17.2% (5) 0.38
) 3.4% (1) 0.29
) 6.9% (2) 0.05
) 6.9% (2) 1
0) 44.8% (13) 0.59
) 41.4% (12) 0.29
) 3.4% (1) 0.29
) 3.4% (1) 0.07
) 20.7% (6) 0.22
1) 44.8% (13) 0.38
) 13.8% (4) 1
65) 42 (35-45) 0.008
60) 58 (50-60) 0.93
2 11.12.1 0.22
-126) 9.7 (3.2-41.4) 0.07
.76-1.6) 0.85 (0.63-1.17) 0.03
127) 98 (88.5-126.5) 0.9
7-14.8) 12 (7.4-13.9) 0.5
1) 41.4% (12) 0.26
) 10.3% (3) 0.24
) 17.2% (5) 0.18
) 27.6% (8) 0.92
%) 7 (21.4%) 0.002
) 20.7% (6) 1
) 6.9% (2) 0.1
) 17.2% (5) 0.69
6.9% (2) 0.51
) 3.4% (1) 0.03
Figure 2. Kaplan Meier survival curves in patient subgroups.
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troponin levels in 15 IE cases [11]. Although no correlation was
found between poor outcome and troponin levels, two patients
with increased troponin levels died during the hospital stay.
Following this study, Purcell et al. found elevated troponin I levels
in 65% of the 51 IE patients [7]. Composite outcome of death,
cerebrovascular events, and abscess formation were correlated
with troponin levels. Similarly, Tsenovoy et al. reported elevated
troponin I levels in 57% of 62 IE patients who also had signiﬁcantly
higher mortality and surgery rates [12]. Finally, in a study with
42 IE patients, Stancoven et al. demonstrated that patients with a
troponin I level of 0.08 ng/ml (n=16, 38%) were more likely to
experience composite outcome of death, central nervous system
event, and cardiac abscess [13]. Furthermore, troponin measure-
ments improved the prognostic value of N-terminal pro-B-type
natriuretic peptide levels in previous studies conducted in patients
with IE [6,14]. In these studies, patients with elevated troponin and
N-terminal pro-B-type natriuretic peptide levels were found to be
at high risk for poor outcome.
Although our results conﬁrm the previous work that demon-
strated inverse relationship between increased troponin levels and
survival, the mechanism behind this association remains unclear.
Elevated troponin levels reﬂect myocardial injury and there are
potential explanations of this in the absence of obstructiveTable 2
Results of the univariate and multivariate Cox regression analysis to predict 1-year mo
Univariate Analysis 
HR (95% CI) 
Age 1.01 (0.99-1.04) 
Female gender 0.55 (0.21-1.42) 
Troponin  0.05 ng/ml 3.83 (1.52-9.67) 
Hemoglobin 0.81 (0.66-1.01) 
Pulmonary artery pressure 1.03 (1.007-1.06) 
Nosocomial infection 3.01 (1.13-7.99) 
Surgery 0.23 (0.05-0.99) 
S. Aureus infection 2.72 (1.07-6.89) 
Valvular destruction/dehiscence 3.18 (1.14-8.86) 
Severe valvular regurgitation 3.47 (1.43-8.41) 
Heart failure 5.63 (2.31-13.73) 
Renal failure 7.09 (2.35-21.44) 
Cardiac abscess 2.73 (0.9-8.23) coronary artery disease. Local invasion of the myocardium may
be a possible mechanism [7,13,15]. In our study, patients with
elevated troponin levels tended to have more cardiac abscess and
higher valvular or paravalvular complication rates. Moreover,
enterococci species were common in these patients. These ﬁndings
were consistent with previous studies [11,12]. Enterococci infec-
tion is more common in patients with prosthetic IE, device related
IE or nosocomial infection. In our cohort, the rates of device
infection (15.8% vs. 3.4%) and nosocomial infection (31.6% vs. 6.9%)
were higher in patients with elevated troponin levels, but
prosthetic valve was less common in this group (31.6% vs.
55.2%). Although the rate of enterococci infection was higher in
troponin available group (12.5% vs. 2.8%) it was not statistically
signiﬁcant and we could not exclude the presence of selection bias
in these patients. Another potential explanation of the increased
troponin levels may be coronary embolism, which may be
observed in the course of IE, although many cases may remain
asymptomatic according to necropsy ﬁndings [15–17]. In our
cohort, no patient presented with ischemic changes on electro-
cardiograms or had overt myocardial infarction. Increased
myocardial stress in the setting of oxidative stress and inﬂamma-
tory response may cause the myocardial damage, similar to
troponin increase seen in sepsis [18]. Troponin elevation in IE may
also represent a more extensive infection. In our cohort, a modest
correlation between troponin and CRP levels was present, similar
to association reported by Watkins et al. [11].
Several years ago Saphir et al. and Perry et al. examined
myocardial lesions in a substantial number of the postmortem IE
patients [19,20]. Following these studies, Buchbinder et al.
described necropsy ﬁndings in patients with left-sided IE
[15]. Multiple histologic sections were examined in 38 patients
and 87% of the cases had myocardial lesions including necrosis,
myocardial inﬂammation and ﬁbrosis. Of the examined cases,
21 patients had interstitial myocardial ﬁbrosis, 22 had papillary
muscle necrosis, and 3 had left ventricular free wall necrosis.
Despite papillary muscle necrosis, no patient had overt mitral
regurgitation and only 3 cases with papillary muscle necrosis had
coronary artery involvement. Except for papillary muscle necrosis,
other myocardial lesions did not correlate with the clinical heart
failure. These observations may explain the prevalence of troponin
elevation in patients with IE and the role of IE in predicting poor
prognosis, as many cases with the myocardial involvement
remained asymptomatic [13].
In our study cohort, patients with elevated troponin levels
had higher creatinine levels and systolic pulmonary artery
pressures. Troponin elevation is common in patients with renal
disease [21]. Increased pulmonary pressure may reﬂect valvularrtality
Multivariate Analysis
p value HR (95% CI) p value
0.44
0.22
0.005 3.11 (1.13-8.56) 0.028
0.06
0.014
0.03
0.05
0.04
0.03
0.006
<0.0001 4.48 (1.73-11.61) 0.002
0.001 8.23 (2.53-26.9) <0.0001
0.08
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were common in patients with elevated troponin levels but the
difference was not statistically signiﬁcant.
5. Conclusion
In conclusion, baseline troponin T levels may provide valuable
information regarding the long-term outcome of the IE and
potentially identify high-risk patients that need more aggressive
treatment. Without an evidence of such a myocardial injury, IE
may have a benign course.
Limitations
This is a single center study and the results may not reﬂect the
properties of the general population. The mean age of the study
subjects was lower and prosthetic valve was more common than
that of western countries [22]. This is probably due to high
prevalence of rheumatic valve disease in our country [23].
Retrospective design and small sample size are other main
limitations. IE related complications and mortality rates were high.
Our institution is a tertiary care center and the patient group may
have had more co-morbid conditions as more severe or compli-
cated cases referred from other institutions. Even though troponin
T levels were measured upon hospital admission, patients may
have presented in different stages of the disease. Serial measure-
ments of troponin were not performed and most cases were
already on treatment; therefore we may have underestimated the
troponin positive cases. Since troponin T levels were measured
only in some of the admitted IE patients for clinical reasons,
sampling strategy may have led a selection bias. The unavailability
of the troponin measurements in all subjects may have had a
signiﬁcant impact on our ﬁndings. Finally, small sample size and
limited number of outcome events may have caused wider
conﬁdence intervals in the regression analysis.
Conﬂict of interest: None declared
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.ijid.2015.03.004.
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